Auburn Hills, MI, United States of America

Tianle Xu

This inventor holds 1 USPTO granted patent. Top assignee: Biosteed Gene Expression Tech. Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tianle Xu. Retrieved from https://idiyas.com/inventor/tianle-xu-04orb4sl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tianle Xu in Biotechnology

Introduction

Tianle Xu is a notable inventor based in Auburn Hills, MI (US). He has made significant contributions to the field of biotechnology, particularly in the development of modified interferon therapies. His work focuses on enhancing the efficacy of treatments for viral infections.

Latest Patents

Tianle Xu holds a patent for "Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof." This invention relates to interferon-α2b modified with Y-shaped branched polyethylene glycol (PEG) at a single Lys residue. The peglated interferon-α2b can be utilized in the preparation of a medicament for treating diseases, such as viral infections like Hepatitis C. He has 1 patent to his name.

Career Highlights

Tianle Xu is associated with Biosteed Gene Expression Tech. Co., Ltd., where he continues to innovate in the field of gene expression and therapeutic development. His work has the potential to significantly impact the treatment of viral diseases.

Collaborations

Some of his notable coworkers include Weidong Zhou and Qingjiang Xiao, who contribute to the collaborative efforts in their research and development projects.

Conclusion

Tianle Xu's innovative work in biotechnology, particularly with his patented modifications to interferon therapies, showcases his commitment to advancing medical treatments. His contributions are vital in the ongoing fight against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…